Tamba, Mikako
Osumi, Hiroki
Ogura, Mariko
Fukuoka, Shota
Okamura, Akihiko
Kanamori, Jun
Imamura, Yu
Yoshino, Koichiro
Udagawa, Shohei
Wakatsuki, Takeru
Shinozaki, Eiji
Watanabe, Masayuki
Yamaguchi, Kensei
Chin, Keisho
Ooki, Akira
Article History
Received: 27 November 2024
Accepted: 24 March 2025
First Online: 8 April 2025
Declarations
:
: This study involves human participants and was approved by the Certified Review Board at the Cancer Institute Hospital of Japanese Foundation for Cancer Research (IRB number: 2023-GB-158). The protocol was described on the hospital website, and subjects were provided the opportunity to opt-out; therefore, no additional consent was required from patients.
: Consent for publication was obtained from the patients.
: The authors declare no competing interests.
: Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this study.